0001104659-24-031939.txt : 20240307
0001104659-24-031939.hdr.sgml : 20240307
20240307165959
ACCESSION NUMBER: 0001104659-24-031939
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240305
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Susan Laura
CENTRAL INDEX KEY: 0001901039
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 24731052
MAIL ADDRESS:
STREET 1: 5 OVERLOOK CT
CITY: LAMBERTVILLE
STATE: NJ
ZIP: 08530
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
4
1
tm248257-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-05
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001901039
Smith Susan Laura
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVENUE, SUITE 3350
NEW YORK
NY
10169
0
1
0
0
SVP & CHIEF COMMERCIAL OFFICER
0
Common Stock
2024-03-05
4
S
0
1682
16.55
D
33918
D
Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units.
/s/ John LaRocca, Attorney-in-Fact
2024-03-07